Cardiology Group Says Don’t Panic over ‘Enhance’
JGrimes
In an unusual step, the American College of Cardiologists has weighed in on the flap over the controversial test of cholesterol-fighter Vytorin, marketed jointly by Merck & Schering-Plough.
The results from the trial, called Enhance, failed to show a benefit of Vytorin (and its ingredient Zetia) over Zocor, or simvastatin, on a measurement of […]